-
J Coll Physicians Surg Pak · Aug 2020
Observational StudyEnzalutamide Treatment in Metastatic Castration-resistant Prostate Cancer: Before and after Docetaxel.
- Irem Bilgetekin, Fatma Bugdayci Basal, Havva Yesil Cinkir, Ece Esin, Berna Oksuzoglu, and Umut Demirci.
- Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.
- J Coll Physicians Surg Pak. 2020 Aug 1; 30 (8): 815-821.
AbstractABSTRACT Objective: To evaluate the efficacy and safety of enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) in docetaxel-naive and docetaxel-pretreated patients.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.